NCOA3 and non-small cell lung carcinoma: Recently, it was discovered that thevebioside (THB), an active component from traditional Chinese medicine, specifically suppressed the expression of SRC-3 via ubiquitin–proteasome-mediated degradation, but not SRC-1 and SRC-2, thus inhibiting the proliferation of NSCLC cells [158].